3D/L Capital Management’s WisdomTree International SmallCap Dividend Fund DLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-240,789
Closed -$13.8M – 24
2023
Q3
$13.8M Sell
240,789
-9,231
-4% -$552K 4.5% 9
2023
Q2
$14.9M Sell
250,020
-11,880
-5% -$725K 4.3% 10
2023
Q1
$16M Sell
261,900
-11,263
-4% -$690K 4.23% 10
2022
Q4
$15.8M Buy
273,163
+829
+0.3% +$46.1K 4.26% 10
2022
Q3
$14M Buy
272,334
+14,322
+6% +$834K 4.16% 10
2022
Q2
$15.1M Sell
258,012
-45,446
-15% -$2.9M 4.21% 10
2022
Q1
$20.8M Buy
303,458
+896
+0.3% +$62.9K 5.13% 9
2021
Q4
$22.3M Buy
302,562
+2,746
+0.9% +$202K 5.21% 8
2021
Q3
$22.3M Buy
299,816
+153
+0.1% +$11.6K 5.34% 9
2021
Q2
$22.4M Sell
299,663
-8,373
-3% -$632K 5.35% 9
2021
Q1
$22.2M Buy
308,036
+307,713
+95,267% +$21.8M 5.64% 8
2020
Q4
$22K Buy
+323
New +$20.5K 0.03% 70

Other funds holding DLS

3D/L Capital Management's DLS Position: Q4 2023 in Review

3D/L Capital Management sold out of WisdomTree International SmallCap Dividend Fund (DLS) in Q4 2023, closing a stake of 240,789 shares — an estimated $13.8M sold.

3D/L Capital Management first reported a position in DLS in Q4 2020 and held it in 12 quarters. The position peaked at $22.4M in Q2 2021. 206 funds tracked by Wall St. Rank hold DLS as of Q4 2023.

  • 3D/L Capital Management reported no remaining WisdomTree International SmallCap Dividend Fund position as of Q4 2023 after selling out during the quarter.
  • 3D/L Capital Management sold 240,789 WisdomTree International SmallCap Dividend Fund shares in Q4 2023, an estimated $13.8M.
  • 3D/L Capital Management first reported a position in WisdomTree International SmallCap Dividend Fund in Q4 2020 and held it in 12 quarters.
  • 3D/L Capital Management's WisdomTree International SmallCap Dividend Fund position peaked at $22.4M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held WisdomTree International SmallCap Dividend Fund as of Q4 2023.

Based on 3D/L Capital Management's 13F filing for Q4 2023.